Malignant neoplasm of ovary
Conditions
Interventions
This is a two-arm, single-blind, randomized clinical study. Experimental group: 42 women with endometrial or ovarian cancer undergoing chemotherapy treatment will receive home exercise guidance and wi
Sponsors
Hospital do Cancer II
Hospital do Cancer II
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: protocol of carboplatin associated with paclitaxel at a high dose; curative intent; ovarian cancer; endometrial cancers
Exclusion criteria
Exclusion criteria: previous chemotherapy treatment; pre-existing neuropathy; metastases unstable bone fractures; cardiac pacemaker; lower limb surgeries in the last year; presence of metallic prostheses; deep venous thrombosis for less than 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the emergence of peripheral neuropathy during the course of chemotherapy, verified by physical assessment and questionnaire, showing changes in any of the evaluated items | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate functional loss during chemotherapy treatment, using the sit-to-stand test, in pre- and post-intervention measurements. Functional loss will be considered if the test execution time increases | — |
Countries
Brazil
Contacts
Public ContactRenata Marchon
Hospital do Cancer II
Outcome results
None listed